Lucia PASTORE CELENTANO, MD, MSc
Head of the Vaccine Preventable Diseases Programme, ECDC
“Addressing vaccine hesitancy in challenging times”
European Health Forum Gastein, 05 October 2017
Presentation at the EU session "Elimination of hepatitis B and C in the EU: challenges and opportunities", at the International Liver Congress (ILC) 2017, Amsterdam.
Presenter: Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Lucia PASTORE CELENTANO, MD, MSc
Head of the Vaccine Preventable Diseases Programme, ECDC
“Addressing vaccine hesitancy in challenging times”
European Health Forum Gastein, 05 October 2017
Presentation at the EU session "Elimination of hepatitis B and C in the EU: challenges and opportunities", at the International Liver Congress (ILC) 2017, Amsterdam.
Presenter: Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
During the first 2 months of 2017 we have seen 1524 cases of measles reported from 14 EU/EEA countries. Measles does not only affect children but also older age groups. In 2014 over half of the cases were in adults over 20 years old, in 2015 and 2016 this age group accounted for approximately one third of all cases. Closing immunisation gaps in adolescents and adults who have not received vaccination in the past as well as strengthening routine childhood immunisation programmes will be vital to prevent future outbreaks and reach the elimination goal.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Speech by: Alexis Goosdeel, EMCDDA Director (European Monitoring Centre for Drugs and Drug Addiction)
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Tonio Piscopo, Mater dei Hospital
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
The usability of STAMP in drug development Arete-Zoe, LLC
Arete-Zoe in cooperation with Stuttgart University
Study authors: Veronika Valdova, Ronald L Sheckler, Asim Abdulkhaleq and Stefan Wagner (Jonathan M Fishbein)
Presentation of synopsis: Veronika Valdova
Presented at STAMP team meeting, PSCI, ACRES on February 26, 2016
Using telehealth to accelerate biomedical HIV preventionYTH
Telemedicine is a collection of means or methods for enhancing health care, public health and health education delivery and support using telecommunications technologies. With more than 95% of adults, and 100% of young adults between the age of 18-29 owning a cell phone in the United States, a technology-based health intervention can be available to hard-to-reach populations or underserved areas.
Panelists will engage a rich dialogue and showcase innovative and effective ways to create prevention programs for HIV and STDs using the potential telehealth can offer, specifically with linking young people to HIV pre-exposure prophylaxis, or PrEP. This plenary brings together leaders in the field of HIV prevention, research and policy along with private organizations and companies that are currently active on the field of biomedical prevention.
Using telehealth to accelerate biomedical HIV preventionYTH
Telemedicine is a collection of means or methods for enhancing health care, public health and health education delivery and support using telecommunications technologies. With more than 95% of adults, and 100% of young adults between the age of 18-29 owning a cell phone in the United States, a technology-based health intervention can be available to hard-to-reach populations or underserved areas.
Panelists will engage a rich dialogue and showcase innovative and effective ways to create prevention programs for HIV and STDs using the potential telehealth can offer, specifically with linking young people to HIV pre-exposure prophylaxis, or PrEP. This plenary brings together leaders in the field of HIV prevention, research and policy along with private organizations and companies that are currently active on the field of biomedical prevention.
ECDC symposium "Responding to two of the main STI threats of our time: syphilis and antimicrobial resistant Neisseria gonorrhoeae"
Presentation by: Otilia Mårdh
Presented at: IUSTI 2019, Tallinn
Improving the understanding of chlamydia epidemiology in Europe –scoping for the rationale of a European Union prevalence survey.
Across Europe, there is considerable variation in reported chlamydia cases by country - likely mirroring substantial heterogeneity in testing, diagnostics and surveillance rather than differences in prevalence.
A European-wide survey has been proposed as a means of improving understanding of the epidemiology of chlamydia in Europe.
This poster was presented at the 8th meeting of the European Society for Chlamydia Research, ESCR, 2016.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
During the first 2 months of 2017 we have seen 1524 cases of measles reported from 14 EU/EEA countries. Measles does not only affect children but also older age groups. In 2014 over half of the cases were in adults over 20 years old, in 2015 and 2016 this age group accounted for approximately one third of all cases. Closing immunisation gaps in adolescents and adults who have not received vaccination in the past as well as strengthening routine childhood immunisation programmes will be vital to prevent future outbreaks and reach the elimination goal.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Speech by: Alexis Goosdeel, EMCDDA Director (European Monitoring Centre for Drugs and Drug Addiction)
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Tonio Piscopo, Mater dei Hospital
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
The usability of STAMP in drug development Arete-Zoe, LLC
Arete-Zoe in cooperation with Stuttgart University
Study authors: Veronika Valdova, Ronald L Sheckler, Asim Abdulkhaleq and Stefan Wagner (Jonathan M Fishbein)
Presentation of synopsis: Veronika Valdova
Presented at STAMP team meeting, PSCI, ACRES on February 26, 2016
Using telehealth to accelerate biomedical HIV preventionYTH
Telemedicine is a collection of means or methods for enhancing health care, public health and health education delivery and support using telecommunications technologies. With more than 95% of adults, and 100% of young adults between the age of 18-29 owning a cell phone in the United States, a technology-based health intervention can be available to hard-to-reach populations or underserved areas.
Panelists will engage a rich dialogue and showcase innovative and effective ways to create prevention programs for HIV and STDs using the potential telehealth can offer, specifically with linking young people to HIV pre-exposure prophylaxis, or PrEP. This plenary brings together leaders in the field of HIV prevention, research and policy along with private organizations and companies that are currently active on the field of biomedical prevention.
Using telehealth to accelerate biomedical HIV preventionYTH
Telemedicine is a collection of means or methods for enhancing health care, public health and health education delivery and support using telecommunications technologies. With more than 95% of adults, and 100% of young adults between the age of 18-29 owning a cell phone in the United States, a technology-based health intervention can be available to hard-to-reach populations or underserved areas.
Panelists will engage a rich dialogue and showcase innovative and effective ways to create prevention programs for HIV and STDs using the potential telehealth can offer, specifically with linking young people to HIV pre-exposure prophylaxis, or PrEP. This plenary brings together leaders in the field of HIV prevention, research and policy along with private organizations and companies that are currently active on the field of biomedical prevention.
ECDC symposium "Responding to two of the main STI threats of our time: syphilis and antimicrobial resistant Neisseria gonorrhoeae"
Presentation by: Otilia Mårdh
Presented at: IUSTI 2019, Tallinn
Improving the understanding of chlamydia epidemiology in Europe –scoping for the rationale of a European Union prevalence survey.
Across Europe, there is considerable variation in reported chlamydia cases by country - likely mirroring substantial heterogeneity in testing, diagnostics and surveillance rather than differences in prevalence.
A European-wide survey has been proposed as a means of improving understanding of the epidemiology of chlamydia in Europe.
This poster was presented at the 8th meeting of the European Society for Chlamydia Research, ESCR, 2016.
Poster presentation at the AIDS 2018 conference in Amsterdam.
By: Marieke J. van der Werf and Csaba Ködmön, European Centre for Disease Prevention and Control, ECDC.
Is Europe ready for elimination of hepatitis B and C? The World Health Organization (WHO) will launch a global strategy on viral hepatitis in 2016 with the aim to eliminate hepatitis B and C as public health threats by 2030. The joint poster from ECDC, EMCDDA and WHO/Euro looks at the current availability of data for each of the core indicators and how existing gaps in data availability could be addressed.
Levels of Utilization and Socio - Economic Factors Influencing Adherence to U...inventionjournals
The paper intends to assess the level of utilization and socio-economic factors influencing adherence to utilization of Anti Retroviral Therapy (ART) for People Living with HIV/AIDS in Dodoma Municipality and Kongwa District in Tanzania. Documentary review, interview and Focus Group Discussion were used in collecting data. A total of 140 respondents (99 PLWHIV/AIDS and 41 key informants) from four hospitals, two health centers and one dispensary were selected and interviewed as representatives for the purpose of this study. Quantitative data were collected and analyzed by using SPSS version 16 software. The study revealed 100% of PLWHIV/AIDS used ART drugs in Dodoma General Hospital, Kongwa Hospital, Mkoka Health Center and Makole Health Center while 40% in St. Gemma Hospital. Also the study indicated there were high dropout from utilization of ART drugs among PLWHIV/AIDS, 60% in Mirembe hospital, (50%) in Mkoka health center and (44%) in St. Gemma hospital as compared to the rest health centers and hospitals. The drop out caused by ART drugs side effects such as vomiting (25.1%), frequently sickness (19.9%) and decrease in CD 4 (11.2%). Lastly the study revealed four main socio-economic factors influencing adherence to utilization of ART services among PLHIV/AIDS including lack of employment support (66.7 %,) lack of confidentiality (50 %,) patient’s preference to traditional medicines (30%) and cultural belief (29.3%). The study recommends all PLWHIV/AIDS with side effects should report their cases to health centers and hospitals because not all side effects require a change of drugs or discontinuation, PLWHIV/AIDS should be assisted by Government and Non-Government Organizations and family members to secure soft loans that will enable them to establish income generation activities, education on patients confidentiality should be provided to services providers in hospitals and health centers
Health related quality of life and multimorbidity in community-dwellingAlfredo Alday
Introduction
Multimorbidity is more common in the elderly population and negatively affects health-related quality of life (QoL). The aims of the study were to report the QoL of users of the Basque telecare public service (BTPS) and to establish its relationship with multimorbidity.
Methods
The EuroQol questionnaire was administered to 1125 users of the service. Their sociodemographic and healthcare characteristics were obtained from BTPS databases and the Basque healthcare service. Multiple regression analysis was performed on the overall questionnaire index to determine the effect of chronic diseases and sociodemographic. Moreover, the effects of the different diseases on specific dimensions of the test were explored by logistic regression.
Results
Of the users interviewed, 82% were women, 88% ≥75 years and 66% lived alone. The average of chronic pathologies was higher among men (5.3 vs. 4.6), for the lower age range and among those not living alone (P < 0.001).>< 0.001).
Conclusions
This study reveals that for the population covered by BTPS the impact of chronic pathologies, multimorbidity and their social context affects QoL very diversely. These diverse social and healthcare needs of community-dwelling elders allow the development and implementation of personalised services, such as telecare that facilitate them to remain at home.
Although HIV is preventable through effective public health measures, significant HIV transmission continues in Europe. In 2015, almost 30 000 people were diagnosed in European Union and European Economic Area Member States; a rate of 6.3 cases in every 100 000 people (when adjusted for reporting delay).
This report, prepared jointly with the WHO Regional Office for Europe, presents data on HIV and AIDS for the whole European Region, including the EU and EEA countries. Analyses are provided for the EU and EEA region.
Monitoring and Evaluation Toolkit - Séances Pratiques de la 5e édition du Cours international « Atelier Paludisme » - Luciano TUSEO - World Health Organization / Roll Back Malaria - Office for Madagascar and Reunion - Antananarivo, Madagascar - maloms@iris.mg
Abstract. The Ministry of Health and Social Services in Namibia under the division of epidemiology uses a manual
paper-based approach to capture disease surveillance data through 5 levels of reporting which include the community level, the health facility level, the district level, and the national level. As a result, this method of communicating
and exchanging disease surveillance information is cost and time consuming, which delay disease surveillance information from reaching the head office on time.
This paper presents analysis of a Kent ‘whole population’ dataset, linking wholepopulation demographics with activity and cost data for the population from acute, community, mental health and social care providers. The data helps commissioners to understand the impact of different selections methods for people with ‘very complex’ health and social care needs, particularly in relation to the development of a LTC year of care currency.
This document should be seen alongside the ‘Recovery, Rehabilitation and Reablement – step-by-step guide’ which describes how providers can carry out the audit in their own organisation. Other documents and learning materials This document is part of a suite of learning materials being produced by the LTC Year of Care Commissioning Programme to support the spread and adoption of capitated budgets for people with complex care needs.
This fourth edition of Health at a Glance: Europe presents key indicators of health and health systems in the 28 EU countries, 5 candidate countries to the EU and 3 EFTA countries. This 2016 edition contains two main new features: two thematic chapters analyse the links between population health and labour market outcomes, and the important challenge of strengthening primary care systems in European countries; and a new chapter on the resilience, efficiency and sustainability of health systems in Europe, in order to align the content of this publication more closely with the 2014 European Commission Communication on effective, accessible and resilient health systems. This publication is the result of a renewed collaboration between the OECD and the European Commission under the broader "State of Health in the EU" initiative, designed to support EU member states in their evidence-based policy making.
Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...IjcmsdrJournal
Background:The use of CD4+ T Lymphocyte count as a vital component to ascertain the stage of HIV/AIDS disease as well as monitor the progress of the disease continues to take centre stage in the management of HIV/AIDS in Africa and beyond. Most health centres in Sub-saharan Africa rely on cut off reference values from different races and distant parts of the world.
Aim:This study was designed to establish the range of CD4+ T Lymphocyte counts among the HIV-negative individuals and also HIV-positive patients at initial booking in the anti-retroviral clinic of our hospital where clinical diagnosis was established.
Methods:Patients were recruited into the study as they report to the hospital on daily basis; structured questionnaires were administered where socio-demograhic and relevant clinical information were obtained. Blood samples (3-5mls) were collected using aseptic techniqueand processed where HIV screening was conducted, and CD4+ T Lymphocyte cell count was carried out using Cyflow (Partec, Germany). Results were fed into Microsoft excel 2007 version and analysed using SPSS 14.
Results:A total of 386 HIV-positive and 145 HIV-negative individuals were recruited into the study. The average CD4+ T Lymphocytes count among the HIV negative individuals was 850 cells /μL and ranged from 200 to 1950 cells/μL with CD4+ T Lymphocyte counts of less than 300 cells/μL being 5 (3.4%). The CD4+ T Lymphocyte counts of less than 500 cells/μL among the HIV-negative individuals was 19(13.1%). However, the CD4+ T Lymphocyte counts among HIV-infected individuals ranged from 50 to 1450 cells/μL, 0.8% (n=3) while 45.9% (n=177) presented with CD4+ T Lymhocyte counts of 50 or less and less than 250 cells/μL respectively. The fact that 75.9% (n=293) of the patients had a CD4+ T Lymphocyte counts of less than 500 cells/μL shows the general late presentation of patients with HIV infection at our health settings, and as much as 50% of these were aware of their HIV status the very first time.
Similar to Social determinants and risk factors for tuberculosis; need for harmonisation of definitions in the EU/EEA? (20)
Summary slides on the epidemiological situation in the EU/EEA.
2018 surveillance data.
Report and ppt slides available from: http://bit.ly/HIVAIDSsurv18
Presentation during the 17th European AIDS Conference (EACS) 2019 looking at the status of HIV pre-exposure prophylaxis PrEP in Europe..
Presenter: Teymur Noori, European Centre for Disease Prevention and Control (ECDC)
Presentation from the opening session of the 17th European AIDS Conference (EACS) 2019, Basel, Switzerland.
Presenter: Anastasia Pharris, European Centre for Disease Prevention and Control.
Hepatitis E is one of the most common causes of acute hepatitis in the EU/EEA but currently not notifiable at EU level.
This presentation summarises ECDC's work on the topic and survey results on hepatitis E on 2005 to 2015 data.
Any questions? Contact press@ecdc.europa.eu
This presentation summarises the main data from the ECDC Annual epidemiological reports 2017 on chlamydia, gonorrhoea, lymphogranuloma venereum, (congenital) syphilis
Providing an overview on data, trends and summary of findings on the hepatitis B and C surveillance data from EU/EEA countries for the year 2017:
Find ECDC's Annual Epidemiological reports online: http://bit.ly/ECDCAER
HIV transmission remains a major public health concern and affects more than 2 million people in the WHO European Region.
These ECDC slides summarise findings from the report which is available via http://bit.ly/WAD_18
Presentation at European Harm Reduction Conference
Bucharest, 21 November 2018
Author Anastasia Pharris, European Centre for Disease Prevention and Control (ECDC)
What is the current situation of HIV in Europe and Central Asia?
How can we more effectively prevent new infections?
Presentation by Anastasia Pharris,
European Centre for Disease Prevention and Control (ECDC)
at Glasgow HIV Drug Therapy Conference
28 October 2018
Data and trends from the ECDC Annual Epidemiological reports for 2016 on:
Chlamydia (http://bit.ly/AERch16)
Lymphogranuloma venereum (http://bit.ly/AERLGV16)
Gonorrhoea (http://bit.ly/AERsy16)
Syphilis (http://bit.ly/AERsy16)
Congenital syphilis (http://bit.ly/AERcs16)
See also: https://ecdc.europa.eu/en/annual-epidemiological-reports
Teymur Noori, ECDC
22nd International AIDS Conference, Amsterdam 2018
2018 European African HIV/AIDS & Hepatitis C Community Summit. "Our Voices Matter for a lasting solution!!"
More from European Centre for Disease Prevention and Control (20)
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Social determinants and risk factors for tuberculosis; need for harmonisation of definitions in the EU/EEA?
1. Background
• In most countries of the European Union (EU) and European Economic Area (EEA), tuberculosis (TB) rates are declining. However, this
trend is not uniform and may mask high TB rates in a subpopulation associated with a specific socioeconomic status and risk factor.
• In 2014, the Wolfheze Working Group conducted a survey among all 53 countries of the WHO European Region to investigate which social
determinants and risk factors for TB are collected in national TB surveillance systems.
• ECDC conducted a follow-up study in the EU/EEA Member States (MS).
Conclusions
EU/EEA Member States collect data on a large number of different social determinants and risk factors for TB and use different definitions, data
collection methods, diverse categories and data sources. Improving comparability of data on social determinants and risk factors by harmonizing
definitions, categories and data collection methods would allow for better inter-country comparisons.
tuberculosis@ecdc.europa.eu
www.ecdc.europa.eu
Methods
• A semi-structured questionnaire was sent to TB surveillance
contact points of 31 EU/EEA Member States by ECDC in
September 2015.
• The answers were grouped by concepts and evaluated using
descriptive analysis.
Social determinants and risk factors for tuberculosis;
need for harmonisation of definitions in the EU/EEA?
Vahur Hollo, Brigita Molnarova, Marieke J. van der Werf
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Table 1. TB social determinant concepts collected in more
than 50% of countries responding to the survey in EU/EEA,
2015
Results
Figure. Responders to the Social Determinants
questionnaire, EU/EEA, 2015
Objective
• To document the definitions of social determinants and risk factors
of TB as used by the national surveillance systems to be able to
provide options for interventions for tuberculosis prevention and
control in hard to reach and vulnerable populations in the EU/EEA.
Collected
(N of countries)
% of countries
collecting
Origin* 27 100%
Place of birth* 26 96%
Current imprisonment* 21 78%
Citizenship (nationality)* 17 63%
Homelessness 17 63%
Employment status 16 59%
Years since entering
reporting country
15 56%
Urban/rural residence 14 52%
Table 2. TB risk factor concepts collected in more than 50%
of countries responding to the survey in EU/EEA, 2015
Collected
(N of countries)
% of countries
collecting
Contact with TB case 22 81%
HIV infection* 20 74%
Diabetes mellitus 15 56%
Use of alcohol 14 52%
Use of illicit drugs 14 52%
Twenty-seven (87%) of 31 countries responded to the survey. In
addition to social determinants already collected at European level, 21
different social determinants were collected by at least one country.
This is in addition to social determinants collected already at European
level (origin, imprisonment). More than half of the countries collects
data on homelessness, employment status, living in urban/rural
settings (Table 1).
Responded
No response
Information regarding potential risk factors for TB, such as known TB
contacts, diabetes, use of alcohol and illicit drugs are collected also by
more than half of responders (Table 2). Similar or greater variations
apply to the collection of risk factors for TB.
For example, information on alcohol consumption is collected by 14
countries. However it is defined in multiple ways and collected among
others as alcohol dependency, alcohol use or misuse, treating doctor’s
assessment of the patient’s ability to adhere to treatment, etc. This is
measured by a variety of ways, such as by using ICD code, according
to national standards, Cage score, judgement of the attending
physician, WHO proposed definitions, etc.
* Already included to the joint ECDC/WHO TB data collection system,
usually well defined
Countries collect data on the same social determinants from a variety
of data sources (e.g. national vital registries, notification forms for
homelessness and ethnicity) or by using different definitions and/or
categories with varied levels of detail.
For example, information on employment is collected by 16 (59%)
countries, but most of them record employment differently. Some
countries record only current status of employment (categories:
employed, unemployed, unknown), while others use broader codes of
occupation or type of activity (categories: unemployed, employed,
disabled, retired, working irregularly, student, other/free text).
Moreover, data are further complicated by the fact that employment
data are also collected according to different age groups in some
countries responding to the survey (e.g. employment information is
collected for ages 15 – 70 years or for all TB cases).
Seven Member States reported merging social case categories on the
TB notification form, e.g. refugees/asylum seekers/undocumented
migrants, which does not allow to determine the specific risk group.
Free text options used, or only ticking a box with risk factor name
does make comparability more difficult; (e.g. if only “Yes” is collected,
are the missing data considered as “No”, or “Unknown”).